FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 188 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,163,616 | -55.5% | 3,379,064 | 0.0% | 2.64% | -47.2% |
| Q2 2023 | $16,084,345 | -16.5% | 3,379,064 | 0.0% | 4.99% | -20.3% |
| Q1 2023 | $19,260,665 | +56391.2% | 3,379,064 | 0.0% | 6.26% | -36.8% |
| Q4 2022 | $34,095 | -100.0% | 3,379,064 | 0.0% | 9.92% | -55.5% |
| Q3 2022 | $75,725,000 | -9.6% | 3,379,064 | 0.0% | 22.28% | +4.2% |
| Q2 2022 | $83,733,000 | -36.1% | 3,379,064 | 0.0% | 21.39% | -13.6% |
| Q1 2022 | $131,006,000 | -33.7% | 3,379,064 | 0.0% | 24.77% | +10.0% |
| Q4 2021 | $197,709,000 | -1.3% | 3,379,064 | 0.0% | 22.51% | +28.1% |
| Q3 2021 | $200,277,000 | – | 3,379,064 | – | 17.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |